Spruce Biosciences Inc
(NAS:SPRB)
$
42.83
-0.54 (-1.25%)
Market Cap: 117.88 Mil
Enterprise Value: 70.92 Mil
PE Ratio: 0
PB Ratio: 1.70
GF Score: 40/100 
Spruce Biosciences Inc at JMP Securities Life Sciences Conference Transcript
Jun 16, 2022 / 03:30PM GMT
Release Date Price:
$109.5
(-8.75%)
Jon Wolleben
JMP Securities LLC - Analyst
Good morning, everybody. My name is Jon Wolleben, senior analyst here at JMP. And pleased to have Spruce Biosciences joining us for a talk. We've got CEO -- recently minted CEO, Javier Szwarcberg. Close?
Javier Szwarcberg
Spruce Biosciences, Inc. - CEO
Close enough.
Jon Wolleben
JMP Securities LLC - Analyst
Close enough. Well, thank you for coming, Javier.
Javier Szwarcberg
Spruce Biosciences, Inc. - CEO
My pleasure.
Questions & Answers
Jon Wolleben
JMP Securities LLC - Analyst
And for those who aren't as familiar with Spruce, this is a company we've been digging into for a little bit of time now. But tell us what you guys are working on.
Javier Szwarcberg
Spruce Biosciences, Inc. - CEO
So, we're working on a compound that inhibits the CRF1 receptor. It's an antagonist of receptor targeting two disease states, one is CAH,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers